Literature DB >> 15004256

Recurrent focal glomerulosclerosis in the era of genetics of podocyte proteins: theory and therapy.

Gian Marco Ghiggeri, Michele Carraro, Flavio Vincenti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15004256     DOI： 10.1093/ndt/gfh173

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  7 in total

1.  Rapid development of glomerular injury and renal failure in mice lacking p53R2.

Authors:  David R Powell; Urvi Desai; Mary Jean Sparks; Gwenn Hansen; Jason Gay; Jeff Schrick; Zheng-Zheng Shi; John Hicks; Peter Vogel
Journal:  Pediatr Nephrol       Date:  2005-01-26       Impact factor: 3.714

2.  Rare functional variants of podocin (NPHS2) promoter in patients with nephrotic syndrome.

Authors:  Roberta Oleggini; Roberta Bertelli; Armando Di Donato; Marco Di Duca; Gianluca Caridi; Simone Sanna-Cherchi; Francesco Scolari; Luisa Murer; Landino Allegri; Rosanna Coppo; Francesco Emma; Giovanni Camussi; Francesco Perfumo; Gian Marco Ghiggeri
Journal:  Gene Expr       Date:  2006

3.  Recurrent Primary Focal Segmental Glomerulosclerosis Managed With Intensified Plasma Exchange and Concomitant Monitoring of Soluble Urokinase-Type Plasminogen Activator Receptor-Mediated Podocyte β3-integrin Activation.

Authors:  Oliver Staeck; Torsten Slowinski; Ina Lieker; Kaiyin Wu; Birgit Rudolph; Danilo Schmidt; Susanne Brakemeier; Hans-Hellmut Neumayer; Changli Wei; Jochen Reiser; Klemens Budde; Fabian Halleck; Dmytro Khadzhynov
Journal:  Transplantation       Date:  2015-12       Impact factor: 4.939

4.  Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.

Authors:  Changli Wei; Shafic El Hindi; Jing Li; Alessia Fornoni; Nelson Goes; Junichiro Sageshima; Dony Maiguel; S Ananth Karumanchi; Hui-Kim Yap; Moin Saleem; Qingyin Zhang; Boris Nikolic; Abanti Chaudhuri; Pirouz Daftarian; Eduardo Salido; Armando Torres; Moro Salifu; Minnie M Sarwal; Franz Schaefer; Christian Morath; Vedat Schwenger; Martin Zeier; Vineet Gupta; David Roth; Maria Pia Rastaldi; George Burke; Phillip Ruiz; Jochen Reiser
Journal:  Nat Med       Date:  2011-07-31       Impact factor: 53.440

5.  Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial.

Authors:  Pietro Ravani; Roberta Rossi; Alice Bonanni; Robert R Quinn; Felice Sica; Monica Bodria; Andrea Pasini; Giovanni Montini; Alberto Edefonti; Mirco Belingheri; Donatella De Giovanni; Giancarlo Barbano; Ludovica Degl'Innocenti; Francesco Scolari; Luisa Murer; Jochen Reiser; Alessia Fornoni; Gian Marco Ghiggeri
Journal:  J Am Soc Nephrol       Date:  2015-01-15       Impact factor: 10.121

Review 6.  Monoclonal antibodies for podocytopathies: rationale and clinical responses.

Authors:  Maddalena Marasà; Jeffrey B Kopp
Journal:  Nat Rev Nephrol       Date:  2009-06       Impact factor: 28.314

7.  Interferon Induced Focal Segmental Glomerulosclerosis.

Authors:  Yusuf Kayar; Nuket Bayram Kayar; Nadir Alpay; Jamshid Hamdard; Iskender Ekinci; Sebnem Emegil; Rabia Bag Soydas; Birol Baysal
Journal:  Case Rep Nephrol       Date:  2016-10-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.